From: Evaluation of plan quality and robustness of IMPT and helical IMRT for cervical cancer
Region of interest | Dose Objective | Weight | Robust |
---|---|---|---|
CTV | Minimum dose 46.8āGy | 70 | On |
Uniform dose 47āGy | 80 | On | |
Maximum dose 48G y | 50 | On | |
External | Dose fall-off: high dose 46.8āGy, low dose 20āGy, 10-mm distance | 10 | Ā |
3-mm ring | Max EUD 45āGy, Aā=ā150 | 5 | Ā |
10-mm ring | Max EUD 20āGy, Aā=ā150 | 5 | Ā |
Bladder | Max Dose 48āGy | 10 | Ā |
Max EUD 30āGy, Aā=ā2 | 5 | On | |
Rectum | Max Dose 48āGy | 10 | On |
Max EUD 30āGy, Aā=ā2 | 5 | Ā | |
Spinal cord | Max Dose 10āGy, A | 2 | Ā |
Bowel | Max Dose 48āGy | 15 | Ā |
Max EUD 30āGy, Aā=ā2 | 5 | Ā | |
Sigmoid | Max Dose 48āGy | 15 | Ā |
Max DVH 40āGy, 20% | 10 | Ā | |
Femoral heads | Max EUD 15āGy, Aā=ā2 | 2 | Ā |